Cardiology
RSSArticles
-
The Growing List of Long-Haul COVID-19 Symptoms
Swedish researchers observe rapid heart rate, dizziness in patients months after viral infection.
-
Modest Improvements in Mortality Rate Disparities in Rural Areas
Black adults living in rural areas in the United States still are more likely to die from diabetes, high blood pressure compared to white adults.
-
What Causes Stroke in Young Patients?
A patient might be young, but he or she could be living with serious, unaddressed medical conditions that can lead to disaster.
-
Defining Patient- and Family-Centered Care Outcomes in the ICU
Using semi-structured interviews with intensive care unit (ICU) survivors and their family members, investigators identified several ICU processes of care and outcomes after the ICU that were important to this population.
-
COVID-19 ARDS Is Associated with Higher Compliance and Lung Gas Volume Compared to Non-COVID-19 ARDS
This retrospective analysis compared historical cohorts with COVID-19-related acute respiratory distress syndrome (ARDS) with respect to compliance and arterial partial pressure of oxygen/fraction of inspired oxygen (P/F) ratios. For comparable P/F ratios, patients with ARDS caused by COVID-19 had higher lung compliance and more lung gas volume.
-
Noninvasive Ventilation in Adult Acute Care: Beyond Clinical Indications
Noninvasive ventilation (NIV) is a commonly used modality in adult acute care. This article examines aspects of NIV that might affect the modality’s success or failure.
-
Evinacumab-dgnb Injection (Evkeeza)
Evinacumab-dgnb should be prescribed as an adjunct to other low-density lipoprotein cholesterol-lowering therapy to treat patients age 12 years and older with homozygous familial hypercholesterolemia.
-
Prednisone vs. Placebo in Short-Term Prevention of Episodic Cluster Headaches
Prednisone, given at 100 mg for five days and then tapering by 20 mg every three days, is a safe and effective short-term prevention for episodic cluster headaches while waiting for longer-acting preventive agents to be initiated.
-
Early Convalescent Plasma to Treat COVID-19 in Elderly Patients with Mild Symptoms
Administering convalescent plasma obtained from survivors of COVID-19 within 72 hours of onset of mild symptoms in elderly patients with the virus was associated with a significant reduction in the risk of development of severe respiratory disease.
-
COVID-19 Patients Can Be Managed Safely with Noninvasive Respiratory Techniques
In adult patients hospitalized with COVID-19 for one month, using a noninvasive respiratory protocol that encouraged high-flow nasal cannula, noninvasive mechanical ventilation, and self-proning did not result in any significant increase in mortality.